Poster exhibition

Abstracts submitted to AIDS 2018 were considered for poster presentation at TB 2018, as well as AIDS 2018 prizes and awards, including the IAS TB/HIV Research Prizes.

Below are abstracts confirmed for the TB 2018 poster exhibition:

Service delivery

  • Addressing high burden of tuberculosis in First Nations communities through the high incidence strategy: An evaluation project in northern Saskatchewan, Canada
    S. Mahmoodi, S. Hourigan, I. Khan, N. Ndubuka
  • Collaborative efforts for improving TB services; A case of PS Kenya in Nyanza region of Kenya, Private sector
    C. Kanari
  • Community Task Forces Making a difference: Increasing TB Case Notification Rates through Community-led TB Campaigns (TBC) in 11 Regions in Tanzania
    G. Asuquo, Y. Ferguson, K. Achebe, M. Imran
  • Engaging private medical practitioners for early HIV screening and treatment initiation of tuberculosis (TB) patients in Maharashtra
    J. Thakker, P. Bogam, R. Taralekar, S. Vijayan, L. Sadasivan, R. Chopra, A. Ali, D. Gangurde, S. Acharya
  • Funding for HIV/AIDS and TB: producing evidence for a successful donor transition in Cambodia
    F. Sophie, B. Johns, H. Nguyen
  • How does integrating HIV and TB services affect health outcomes for HIV-TB co-infected patients in Ukraine? Results from an impact evaluation
    S. Agarwal, S. Curtis, S. Mullen, M. Skiles, Z. Charyeva, K. Brugh, C. Suchindran, O. Zaliznyak, T. Senik, P. Brodish, S. Eagan
  • Human rights barriers to access TB and TB/HIV perceptions by mine workers in 10 Southern Africa Countries (Botswana, Lesotho, Malawi, Mozambique, Namibia, South Africa, Swaziland, Tanzania, Zimbabwe and Zambia)
    L. Busang, B. Fidzani, B. Mbambo, M. Ndhlalambi, J. Mafeni, F. Mwangemi
  • Implementation of HIV Testing Status of TB cases and ART coverage: A descriptive analysis of PEPFAR and National data in 15 countries in East and Southern Africa
    E. Noykhovich, C. Nichols, J.S. Cavanaugh
  • Improved utilization of the National Pediatric and Adolescent HIV/AIDS/TB Call Center through targeted marketing: lessons from Baylor-Uganda
    F.F. Tendo, L. Engurat, J. Balungi Kanywa., A. Kekitinwa
  • Increasing TB case detection and treatment among street children in the slums of Kampala District; the case of Kamwokya Christian Caring Community (KCCC)
    N. Seruma, A. Namugwere, KCCC Study Group
  • Low ART coverage of TB/HIV Infected Patients in Central Asia: Results from Kazakhstan and Kyrgyzstan
    Y. Kudussova, T. Ellman, A. Deryabina
  • Probabilistic recorded linkage as a tool to improve TB-HIV coinfection surveillance in Brazil
    K. Andrade, C.O. Dantas, D.M. Pelissari, M.S. Rocha, L.A. Nascimento Júnior, P.O. Bartholomay, D. Arakaki, R.A. Ribeiro, R. Coelho, A.R.C.d. Cunha, G.F.M. Pereira
  • Risk factors of recurrent TB disease in a setting of high HIV prevalence
    S. Hermans, N. Zinyakatira, J. Caldwell, F. Cobelens, A. Boulle, R. Wood
  • Safety and efficacy of dolutegravir-based ART in TB/HIV co-infected adults at week 48
    K. Dooley, R. Kaplan, T. Mwelase, B. Grinsztejn, E. Ticona, M. Lacerda, O. Sued, E. Belonosova, M. Ait-Khaled, K. Angelis, D. Brown, R. Singh, C. Talarico, A. Tenorio, M. Keegan, M. Aboud
  • Strengthening HIV and tuberculosis surveillance through intensified case finding in a prison in North-East India, 2017
    T. Bhatnagar, M. Ralte, L. Ralte, Chawnglungmuana, L. Sundaramoorthy, L. Chhakchhuak
  • Trend analysis of HIV/TB integrated services utilization and coverage in Uganda Harm Reduction Referral Points in Kampala, Gulu, Mbarara and Mbale
    W.T. Lotic, E. Muhwezi, C. Baguma, S. Ajuna
  • Tuberculosis testing and treatment among people who use drugs in Abidjan: results and perspectives for a community-based approach implemented in Abidjan, Côte d'Ivoire
    A. Bernier, G. Colin, N. Luhmann, L. N'zi, S. Houndji, A. Assoumou2, D. Ramatou, J. Bouscaillou, L.-H. Adjahi, J. Evanno, R. Boulet, C. Doumenc-Aïdara, C. Dézé, A. Kouamé, R. Kouassi N'Guessan, Presenter: E. Wisse

Tuberculosis preventive therapy / Latent TB infection

  • Estimating Latent Tuberculosis Infection Prevalence in the United States: Back-Calculation from Active TB Cases
    A. Mirzazadeh, I.E. Fellows, H. Ashki, A. Parriott, A. Readhead, P. Barry, J. Flood, T.R. Navin, A.N. Hill, S. Reynolds, S. Marks, D. McCabe, J. Mermin, J.G. Kahn, P.B. Shete
  • Health-related quality of life in the A5274 trial (REMEMBER) of empirical tuberculosis (TB) therapy versus isoniazid preventive therapy (IPT) in adult outpatients with advanced HIV
    R. Lando, X. Sun, S. Miyahara, M. Hosseinpour, G. Bisson, J. Kumwenda, A. Gupta, M. Nyirenda, K. Katendey, T. Torres, N. Suryavanshi, F. Beulah, N.S. Shah, A5274 Study Group
  • Policy implementation gap of Isoniazid Preventive Therapy (IPT) among people living with HIV in limited resource setting: lessons from Nepal
    K. Deuba, U. Shrestha, B. Rawal, R.P. Khanal, R.K. Bhattarai, B.D. Pandey, R. Shrestha, A.M. Ekstrom
  • Status of provision of Isoniazid Preventive therapy for People Living with HIV and lessons learnt from the challenges in the programmatic implementation and expansion in India
    D. Balasubramanian, M. Gorla, R. Rao, N. Kumar, M. Bamrotiya, K.S. Sachdeva, R.S. Gupta, S.D. Khaparde, K.K. Rade
  • Task shifting increased IPT uptake and completion among people living with HIV in secondary health facilities southeast Nigeria
    O. Onyedinachi, O. Eghaghara, O. Adebayo, A. Eyo, G. Odutuga
  • The importance and clinical relevance of baseline LTBI screening in HIV patients
    N.S. Wong, C.C. Leung, K. Chan, W.K. Chan, A. Lin, S.S. Lee
  • Toward Improved IPT Implementation for Adolescents Living with HIV in Swaziland: Elucidating the Barriers through the Theory of Planned Behavior
    A. Kay, N. Thivalapill, S. Donald, P. Fuentes, N. Dlamini, P. Ustero, L. Adams, A. Mandalakas
  • Towards 95% completion rates of Isoniazid preventive therapy in resource limited setting; case of Amref Kibera community health centre, Nairobi, Kenya MDR-TB / TB / HIV co-infection
    Z. Muiruri Njogu, D. Wanyama, M. Mungai, S. Karanja, D. Dianga
  • Tuberculosis preventive therapy in PEPFAR countries
    J. Cavanaugh, J. Brown, A. Sanicki, H. Meri, G. Siberry


  • Early Detection of Tuberculosis Consortium (E-DETECT TB)
    G. de Vries, I. Abubakar, L. Barcellini, C. Batt, D. M. Cirillo, S. Collin, A.-M. Duca, K. Lönnroth, V. Marchese, A. Matteelli, J. Nederby Öhd, A. Story, D. Zenner
  • Enhancement of the INSHI case definition for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome using latent class analysis
    C. Stek, J. Buyze, J. Menten, C. Schutz, F. Thienemann, L. Blumenthal, G. Maartens, T. Boyles, R.J. Wilkinson, G. Meintjes, L. Lynen
  • Evaluation of a Prototype cobas®MTB assay for use on the cobas® 6800/8800 Systems for the detection of Mycobacterium tuberculosis in a high burden HIV patient population
    L. Scott, A. David, J. Furrer, F. Schneider, L. Govender, S. Kumar, F. Bastos, S. Lange, P. Loetscher, N. Martinson, E.M. Marlowe, W. Stevens
  • Expanding use of TB-LAM for HIV+ individuals with CD4< 200: Evidence from MSF operational research and beyond
    K. England, E. Fajardo, G. Ferlazzo, H. Huerga
  • Roll out and scale up of WHO-endorsed TB diagnostic technologies to diagnose TB and MDR-TB in African: from Stop TB to End TB Strategy era
    J.D.D. Iragena, F. Jallow, M. Gasana, H. Lago
  • Selective Immune Cell Depletion of Mycobacterium Tuberculosis (Mtb) in Whole-blood Bactericidal Assay (WBA)
    G.B. Cross, B.C. Yeo, M.C. Tan, R. Verma, Q. Lu, N.I. Paton
  • The effect of HIV status on the identification of differentially culturable tubercle bacilli (DCTB) during treatment of drug susceptible tuberculosis
    J.S. Peters, A. Mc Ivor, A. Papadopoulos, T. Masangana, B.G. Gordhan, K. Otwombe, Z. Waja, N. Martinson, F. Shahim, B.D. Kana
  • Using a targeted approach to boost TB case-finding among vulnerable Children- The SMILE Experience
    C. Anoje, T. Lan, E. Olashore, M. Bebia, A. Efuntoye, O. Temitayo, P. Gado
  • Utility of gene Xpert MTB/RIF as a screening assay for tuberculosis in HIV-infected patients from a rural setting of Rakai district, Uganda
    R. Muwanika
  • Yield and efficiency of novel intensified tuberculosis case-finding algorithms for people living with HIV
    C. Yoon, F. Semitala, L. Asege, J. Katende, S. Mwebe, A. Andama, E. Atuhumuza, M. Nakaye, D. Armstrong, D. Dowdy, C. McCulloch, M. Kamya, A. Cattamanchi

MDR-TB / TB / HIV co-infection

  • Clinical outcomes with bedaquiline use when substituted for second-line injectable agents in multidrug resistant tuberculosis: a retrospective cohort study
    Y. Zhao, K. Manning, A. Stewart, T. Fox, N. Tiffin, A. Boulle, V. Mudaly, Y. Kock, G. Meintjes, S. Wasserman
  • Clinical predictors of Mycobacterium tuberculosis bacteremia in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil
    J. Moreira, R. Castro, C. Lamas, M.C. Lourenco, S. Ribeiro, B. Grinsztejn, V.G. Veloso
  • Data driven insight on TB and HIV co-infections amongst high risk groups in Zimbabwe: TaS4TB 2017 operational year
    T. Sengai, F. Kavhenga, G. Shumba
  • Improving survival among HIV positive MDR-TB patients with unsuccessful outcomes after the shorter MDR-TB regimen in high HIV-burden setting. Lessons learnt from the field
    D. Vambe, J. Furin, C. Wawa Mbo, O. Kasay Maha, M.L. Vilane, T. Dlamini, S.M. Haumba
  • Mining areas, one of the hotbeds of tuberculosis and HIV AIDS. Case of mining areas in eastern Democratic Republic of Congo
    O. Rusumba, N. Nyakabwa, V. Bola, F. Birembano, I. Alain
  • Poor Treatment outcome and higher mortality rate among TB/HIV co-infected patients compared to TB without HIV infected patients
    S. Gatechompol, J. Sophonphan, K. Kawkitinarong, G. Suwanpimolkul, P. Kateruttanakul, W. Manosuthi4, S. Ubolyam, S. Kerr,5, A. Avihingsanon, K. Ruxrungtham
  • TB-HIV program monitoring in PEPFAR-supported countries: screening, prevention, and treatment results for children and adults, October 1, 2016 - September 30, 2017
    K. O'Connor, V. Ryan, R. Golin, C. Nichols, G. Anyalechi, H. Kirking, M. Patel
  • Tuberculosis and HIV co-infection in the European Union: Epidemiology and tuberculosis treatment outcomes
    M. van der Werf, C. Ködmön
  • Tuberculosis incidence, risk factors and associated mortality in adults living with HIV, on antiretroviral therapy, in Thailand: a 12-year cohort study
    A. Duclau, N. Salvadori, A. Nechba, S. Kawilapat, E. Cercier, P. Traisathit, S. Khusuwan, P. Kanjanavikai, M. Techapornroong, S. Thongpaen, Y. Buranawanitchakorn, R. Lertkoonalak, P. Sang-a-gad, S. Le Coeur, M. Lallemant, N. Ngo-Giang-Huong, G. Jourdain